Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Seth L. Harrison
AddedMar 31, 2024
UpdatedMay 31, 2026
Seth L. Harrison

Seth L. Harrison

Board Member, Stoke Therapeutics

Crunchbase

Seth L. Harrison's Career

Stoke Therapeutics
Stoke Therapeutics

Bedford, MA, US

Board Member· Board
Nereid Therapeutics
Nereid Therapeutics

Boston, MA, US

Board Member· Board
Aethon Therapeutics
Aethon Therapeutics

New York City, NY, US

Board Member· Board
Apple Tree Partners
Apple Tree Partners

New York City, NY, US

Co-Founder
Nine Square Therapeutics
Nine Square Therapeutics

New York City, NY, US

Board Member· Board
Elstar Therapeutics
Elstar Therapeutics

Cambridge, MA, US

Board Member· Board
Cure Forward
Cure Forward

Boston, MA, US

Board Member· Board
Braeburn
Braeburn

Plymouth Meeting, PA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Seth L. Harrison's Career

Stoke Therapeutics
Stoke Therapeutics
Public$235.1M1172014Bedford, MA, US
Board Member· Board

Leadership at Stoke Therapeutics

Garry E. MenzelGarry E. MenzelBoard Member
Isabel AznarezIsabel AznarezCo-Founder
Jennifer BursteinJennifer BursteinBoard Member
Adrian KrainerAdrian KrainerCo-Founder
Arthur A LevinArthur A LevinBoard Member
Edward KayeEdward KayeBoard Member
Nereid Therapeutics
Nereid Therapeutics
Series A$50M122020Boston, MA, US
Board Member· Board

Leadership at Nereid Therapeutics

Robert HuginRobert HuginBoard Member
Michael KauffmanMichael KauffmanCEO

Similar to Nereid Therapeutics

Faze MedicinesFaze MedicinesCambridge, MA, USTherapeuticsest. 2020Faze MedicinesCambridge, MA, US · est. 2020

Faze Medicines: A pioneering biotech company specializing in biomolecular condensate therapeutics.

Series A · $81M40
Nerio TherapeuticsNerio TherapeuticsLos Angeles, CA, USBiotechest. 2019Nerio TherapeuticsLos Angeles, CA, US · est. 2019

Los Angeles-based biotech company specializing in life sciences. Founded in 2019.

Series A · $6.5M6
Transition BioTransition BioCambridge, MA, USDrug Discoveryest. 2020Transition BioCambridge, MA, US · est. 2020

Transition Bio: Pioneering biomolecular condensate analysis tech for precise drug discovery.

Series A · $50M50
Dewpoint TherapeuticsDewpoint TherapeuticsBoston, MA, USDrug Platformest. 2018Dewpoint TherapeuticsBoston, MA, US · est. 2018

Dewpoint Therapeutics: A global biotech firm developing a drug platform targeting biomolecular condensates.

Series C · $287M161
Aethon Therapeutics
Aethon Therapeutics

New York City, NY, US

Board Member· Board
Apple Tree Partners
Apple Tree Partners
Investment FirmInvestment Firm$5M471999New York City, NY, US
Co-Founder

Leadership at Apple Tree Partners

Mark PruzanskiMark PruzanskiCo-Founder

Similar to Apple Tree Partners

ATPATPAustin, TX, USest. 2014ATPAustin, TX, US · est. 2014

ATP-I: A technology venture fund enabling rapid growth and sustainable success for emerging tech firms.

Investment Firm9
Olive Tree CapitalOlive Tree CapitalBoston, MA, USest. 2016Olive Tree CapitalBoston, MA, US · est. 2016

OT Management, LLC: A specialized investment advisory firm focusing on diverse asset classes.

Investment Firm5
AirTree VenturesAirTree VenturesSurry Hills, New South Wales, AUest. 2014AirTree VenturesSurry Hills, New South Wales, AU · est. 2014

AirTree Ventures: A global venture capital firm specializing in software, finance, digital commerce, media, and marketing.

Investment Firm185
Atherton Venture PartnersAtherton Venture PartnersMenlo Park, CA, USest. 2010Atherton Venture PartnersMenlo Park, CA, US · est. 2010

Atherton Venture Partners: A US-based venture capital firm investing in healthcare, life science, and IT sectors.

Investment Firm5
Nine Square Therapeutics
Nine Square Therapeutics

New York City, NY, US

Board Member· Board
Elstar Therapeutics
Elstar Therapeutics
Series A$39M352015Cambridge, MA, US
Board Member· Board

Leadership at Elstar Therapeutics

Rupert VesseyRupert VesseyBoard Member
Sam HallSam HallBoard Member
Steve ArkinstallSteve ArkinstallCEO
Cure Forward
Cure Forward
Series A$27.8M302014Boston, MA, US
Board Member· Board

Leadership at Cure Forward

Martin NaleyMartin NaleyFounder
Frank IngariFrank IngariCEO
Braeburn
Braeburn

Plymouth Meeting, PA, US

Board Member· Board

Seth L. Harrison's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Seth L. Harrison

Sameer ShalabySameer ShalabyCo-Founder · Select Venture PartnersRaul BraunerRaul BraunerCo-Founder · Bio-Tree SystemsAkash OP AuroraAkash OP AuroraFounder · InfluencRobert GuinnRobert GuinnCEO · AppTree SoftwareKishore GopalakrishnaKishore GopalakrishnaCo-Founder · StarTreeKevin HughesKevin HughesCo-Founder · Branchpoint Technologies